-

Butterfly Network to Participate at the TD Cowen 45th Annual Health Care Conference on March 3, 2025

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will present and host one-on-one investor meetings at the TD Cowen 45th Annual Health Care Conference in Boston on March 3, 2025. Heather Getz, Executive Vice President & Chief Financial and Operations Officer will host one-on-one meetings and will present a business overview at 1:10pm EST.

A webcast of the presentation will be available in the Events & Presentations section of the Butterfly investor website.

About Butterfly Network
Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world’s first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore’s Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly’s innovations have also been recognized by Fierce 50, TIME’s Best Inventions and Fast Company’s World Changing Ideas, among other achievements.

Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: https://www.butterflynetwork.com/choose-your-country.

Contacts

Butterfly Investors:
Heather Getz
Chief Financial and Operations Officers, Butterfly
investors@butterflynetwork.com

Or

Steve Halper
LifeSci Advisors (IR Representative)
646-876-6455
shalper@lifesciadvisors.com

Butterfly Network, Inc.

NYSE:BFLY

Release Versions
$Cashtags

Contacts

Butterfly Investors:
Heather Getz
Chief Financial and Operations Officers, Butterfly
investors@butterflynetwork.com

Or

Steve Halper
LifeSci Advisors (IR Representative)
646-876-6455
shalper@lifesciadvisors.com

Social Media Profiles
More News From Butterfly Network, Inc.

Butterfly Network to Report Third Quarter 2026 Financial Results on October 29, 2026

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report third quarter 2026 financial results on Thursday, October 29, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcas...

Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface

BURLINGTON, Mass. & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Bridge Neurotech ("Bridge"), which emerged from stealth today with the goal of building a completely non-invasive brain-computer interface (BCI), and Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, today announced a research and development agreement through Butterfly Embedded™. Bridge was founded with a mission to make BCIs possible without...

Butterfly Network Appoints Mike Noonen to Board of Directors

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Mike Noonen to its Board of Directors, effective October 9, 2026. Mr. Noonen will serve on the Board's Compensation Committee and Technology Committee. With his appointment, the Board expands to seven directors. Mr. Noonen is a seasoned semiconductor executive with...
Back to Newsroom